Akribion Therapeutics is a series c plus startup based in Germany. 1 investor tracked on Brouky Intelligence. Status: dead. Data sourced from Brouky Intelligence.
About
Akribion Therapeutics is a biotechnology company focused on developing new therapies for cancer.
Stage
series-c-plus
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky